Citations (96)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Miyuki Breen, Caroline L Ring, Anna Kreutz, Michael-Rock Goldsmith & John F Wambaugh. (2021) High-throughput PBTK models for in vitro to in vivo extrapolation. Expert Opinion on Drug Metabolism & Toxicology 17:8, pages 903-921.
Read now
Read now
Donna A. Volpe & Hisham Qosa. (2018) Challenges with the precise prediction of ABC-transporter interactions for improved drug discovery. Expert Opinion on Drug Discovery 13:8, pages 697-707.
Read now
Read now
Miguel Ángel Cabrera-Pérez & Hai Pham-The. (2018) Computational modeling of human oral bioavailability: what will be next?. Expert Opinion on Drug Discovery 13:6, pages 509-521.
Read now
Read now
Elizabeth C. M. de Lange, Willem van den Brink, Yumi Yamamoto, Wilhelmus E. A. de Witte & Yin Cheong Wong. (2017) Novel CNS drug discovery and development approach: model-based integration to predict neuro-pharmacokinetics and pharmacodynamics. Expert Opinion on Drug Discovery 12:12, pages 1207-1218.
Read now
Read now
Slobodan M. Jankovic. (2014) Comparison of EMA and FDA guidelines for drug interactions: An overview. Clinical Research and Regulatory Affairs 31:2-4, pages 29-34.
Read now
Read now
Elliot Offman & Andrea N. Edginton. (2013) Contrasting toxicokinetic evaluations and interspecies pharmacokinetic scaling approaches for small molecules and biologics: applicability to biosimilar development. Xenobiotica 43:6, pages 561-569.
Read now
Read now
Karen Rowland Yeo, Masoud Jamei & Amin Rostami-Hodjegan. (2013) Predicting drug–drug interactions: application of physiologically based pharmacokinetic models under a systems biology approach. Expert Review of Clinical Pharmacology 6:2, pages 143-157.
Read now
Read now
Mario Pellegatti & Sabrina Pagliarusco. (2011) Drug and metabolite concentrations in tissues in relationship to tissue adverse findings: a review. Expert Opinion on Drug Metabolism & Toxicology 7:2, pages 137-146.
Read now
Read now
Articles from other publishers (88)
Ling Pei, Run Li, Hong Zhou, Wenxin Du, Yajie Gu, Yingshuo Jiang, Yongqing Wang, Xin Chen, Jianguo Sun & Junrong Zhu. (2023) A Physiologically Based Pharmacokinetic Approach to Recommend an Individual Dose of Tacrolimus in Adult Heart Transplant Recipients. Pharmaceutics 15:11, pages 2580.
Crossref
Crossref
Ananth K. Kammala, Lauren S. Richardson, Enkhtuya Radnaa, Arum Han & Ramkumar Menon. (2023) Microfluidic technology and simulation models in studying pharmacokinetics during pregnancy. Frontiers in Pharmacology 14.
Crossref
Crossref
Muhammad Talha Zahid, Ammara Zamir, Abdul Majeed, Imran Imran, Sary Alsanea, Tanveer Ahmad, Faleh Alqahtani & Muhammad Fawad Rasool. (2023) A physiologically based pharmacokinetic model of cefepime to predict its pharmacokinetics in healthy, pediatric and disease populations. Saudi Pharmaceutical Journal 31:8, pages 101675.
Crossref
Crossref
Yoo-Seong Jeong & William J Jusko. (2023)
A Complete Extension of Classical Hepatic Clearance Models Using Fractional Distribution Parameter
in Physiologically Based Pharmacokinetics
. Journal of Pharmaceutical Sciences.
Crossref
Crossref
Deepika Deepika & Vikas Kumar. (2023) The Role of “Physiologically Based Pharmacokinetic Model (PBPK)” New Approach Methodology (NAM) in Pharmaceuticals and Environmental Chemical Risk Assessment. International Journal of Environmental Research and Public Health 20:4, pages 3473.
Crossref
Crossref
Timothy J. Carlson. 2023. Overcoming Obstacles in Drug Discovery and Development. Overcoming Obstacles in Drug Discovery and Development
175
187
.
Dave T. F. Kuo, Barnett A. Rattner, Sarah C. Marteinson, Robert Letcher, Kim J. Fernie, Gabriele Treu, Markus Deutsch, Mark S. Johnson, Sandrine Deglin & Michelle Embry. (2022) A Critical Review of Bioaccumulation and Biotransformation of Organic Chemicals in Birds. Reviews of Environmental Contamination and Toxicology 260:1.
Crossref
Crossref
Erik Wollmer & Sandra Klein. (2022) Patient-specific in vitro drug release testing coupled with in silico PBPK modeling to forecast the in vivo performance of oral extended-release levodopa formulations in Parkinson’s disease patients. European Journal of Pharmaceutics and Biopharmaceutics 180, pages 101-118.
Crossref
Crossref
Hyo-jeong Ryu, Won-ho Kang, Taeheon Kim, Jae Kyoung Kim, Kwang-Hee Shin, Jung-woo Chae & Hwi-yeol Yun. (2022) A compatibility evaluation between the physiologically based pharmacokinetic (PBPK) model and the compartmental PK model using the lumping method with real cases. Frontiers in Pharmacology 13.
Crossref
Crossref
Jiaqi Wang, Tom M. Nolte, Stewart F. Owen, Rémy Beaudouin, A. Jan Hendriks & Ad M.J. Ragas. (2022) A Generalized Physiologically Based Kinetic Model for Fish for Environmental Risk Assessment of Pharmaceuticals. Environmental Science & Technology 56:10, pages 6500-6510.
Crossref
Crossref
Zijian Li, Jie Xiong & Yuan Guo. (2022) Physiologically based kinetic model for assessing intermittent chronic internal exposure to chemicals: Application for disinfection by-products in swimming pool water. Computational Toxicology 22, pages 100227.
Crossref
Crossref
Hinojal Zazo, Clara I. Colino, Carmen Gutiérrez-Millán, Andres A. Cordero, Matthias Bartneck & José M. Lanao. (2022) Physiologically Based Pharmacokinetic (PBPK) Model of Gold Nanoparticle-Based Drug Delivery System for Stavudine Biodistribution. Pharmaceutics 14:2, pages 406.
Crossref
Crossref
Kosuke Yoshida, Yuki Doi, Norihiko Iwazaki, Hidenori Yasuhara, Yuka Ikenaga, Hidetoshi Shimizu, Tomohisa Nakada, Tomoko Watanabe, Chise Tateno, Seigo Sanoh & Yaichiro Kotake. (2021) Prediction of human pharmacokinetics for low‐clearance compounds using pharmacokinetic data from chimeric mice with humanized livers. Clinical and Translational Science 15:1, pages 79-91.
Crossref
Crossref
Mehar Sahu, Rohan Gupta, Rashmi K. Ambasta & Pravir Kumar. 2022. Precision Medicine. Precision Medicine
57
100
.
Alan Talevi & Carolina L. Bellera. 2022. The ADME Encyclopedia. The ADME Encyclopedia
349
356
.
Manuel Ibarra, Alejandra Schiavo & Lawrence J. Lesko. 2022. The ADME Encyclopedia. The ADME Encyclopedia
987
995
.
Nishtha Chaurawal & Kaisar Raza. 2022. Pharmacokinetics and Pharmacodynamics of Nanoparticulate Drug Delivery Systems. Pharmacokinetics and Pharmacodynamics of Nanoparticulate Drug Delivery Systems
53
67
.
Bruno Christ, Maximilian Collatz, Uta Dahmen, Karl-Heinz Herrmann, Sebastian Höpfl, Matthias König, Lena Lambers, Manja Marz, Daria Meyer, Nicole Radde, Jürgen R. Reichenbach, Tim Ricken & Hans-Michael Tautenhahn. (2021) Hepatectomy-Induced Alterations in Hepatic Perfusion and Function - Toward Multi-Scale Computational Modeling for a Better Prediction of Post-hepatectomy Liver Function. Frontiers in Physiology 12.
Crossref
Crossref
Kevin Hammon, Greg de Hart, Brian R. Vuillemenot, Derek Kennedy, Don Musson, Charles A. O’Neill, Martin L. Katz & Joshua W. Henshaw. (2021) Dose selection for intracerebroventricular cerliponase alfa in children with CLN2 disease, translation from animal to human in a rare genetic disease. Clinical and Translational Science 14:5, pages 1810-1821.
Crossref
Crossref
Ekram Ahmed Chowdhury, Behnam Noorani, Faleh Alqahtani, Aditya Bhalerao, Snehal Raut, Farzane Sivandzade & Luca Cucullo. (2021) Understanding the brain uptake and permeability of small molecules through the BBB: A technical overview. Journal of Cerebral Blood Flow & Metabolism 41:8, pages 1797-1820.
Crossref
Crossref
Bret BernerToufigh Gordi & Bret Berner. 2021. Drug Delivery Approaches. Drug Delivery Approaches
1
41
.
Zhengying Zhou, Jinwei Zhu, Muhan Jiang, Lan Sang, Kun Hao & Hua He. (2021) The Combination of Cell Cultured Technology and In Silico Model to Inform the Drug Development. Pharmaceutics 13:5, pages 704.
Crossref
Crossref
Daniel E. Dawson, Brandall L. Ingle, Katherine A. Phillips, John W. Nichols, John F. Wambaugh & Rogelio Tornero-Velez. (2021) Designing QSARs for Parameters of High-Throughput Toxicokinetic Models Using Open-Source Descriptors. Environmental Science & Technology 55:9, pages 6505-6517.
Crossref
Crossref
R. Díaz de León–Ortega, D.M. D'Arcy, D.A. Lamprou & N. Fotaki. (2021) In vitro - in vivo relations for the parenteral liposomal formulation of Amphotericin B: A clinically relevant approach with PBPK modeling. European Journal of Pharmaceutics and Biopharmaceutics 159, pages 177-187.
Crossref
Crossref
Manisha Bhateria, C. Yahavi, Anushka Pandey, Shiv Singh & Sheelendra Pratap Singh. 2021. Handbook of Functionalized Nanomaterials. Handbook of Functionalized Nanomaterials
165
196
.
Mohamed Elmeliegy & Oliver Ghobrial. 2021. Remington. Remington
263
280
.
Yu Cheng, Chen-yu Wang, Zi-ran Li, Yan Pan, Mao-bai Liu & Zheng Jiao. (2020) Can Population Pharmacokinetics of Antibiotics be Extrapolated? Implications of External Evaluations. Clinical Pharmacokinetics 60:1, pages 53-68.
Crossref
Crossref
Alan Talevi & Carolina Bellera. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
9
.
Manuel Ibarra, Alejandra Schiavo & Lawrence J. Lesko. 2021. The ADME Encyclopedia. The ADME Encyclopedia
1
9
.
Priyanka R. Kulkarni, Amir S. Youssef & Aneesh A. Argikar. 2021. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
369
417
.
Memoona Rashid, Muhammad Sarfraz, Mosab Arafat, Amjad Hussain, Nasir Abbas, Muhammad Waqas Sadiq, Muhammad Fawad Rasool & Nadeem Irfan Bukhari. (2020) Prediction of lisinopril pediatric dose from the reference adult dose by employing a physiologically based pharmacokinetic model. BMC Pharmacology and Toxicology 21:1.
Crossref
Crossref
Philippe B. Pierrillas, Emilie Henin, Julien Ogier, Magali Amiel, Laurence Kraus-Berthier, Marylore Chenel, François Bouzom & Michel Tod. (2020) Translational approach from preclinical to clinical: comparison of dose finding methods of a new Bcl2 inhibitor using PK-PD modeling and interspecies extrapolation. Investigational New Drugs 38:6, pages 1796-1806.
Crossref
Crossref
Fengxu Wu, Yuquan Zhou, Langhui Li, Xianhuan Shen, Ganying Chen, Xiaoqing Wang, Xianyang Liang, Mengyuan Tan & Zunnan Huang. (2020) Computational Approaches in Preclinical Studies on Drug Discovery and Development. Frontiers in Chemistry 8.
Crossref
Crossref
Letizia Carrara, Paolo Magni, Donato Teutonico, Lorenzo Pasotti, Oscar Della Pasqua & Frank Kloprogge. (2020) Ethambutol disposition in humans: Challenges and limitations of whole-body physiologically-based pharmacokinetic modelling in early drug development. European Journal of Pharmaceutical Sciences 150, pages 105359.
Crossref
Crossref
Jong Bong Lee, Simon Zhou, Manting Chiang, Xiaowei Zang, Tae Hwan Kim & Leonid Kagan. (2020) Interspecies prediction of pharmacokinetics and tissue distribution of doxorubicin by physiologically‐based pharmacokinetic modeling. Biopharmaceutics & Drug Disposition 41:4-5, pages 192-205.
Crossref
Crossref
Edward J. Perkins, Roman Ashauer, Lyle Burgoon, Rory Conolly, Brigitte Landesmann, Cameron Mackay, Cheryl A. Murphy, Nathan Pollesch, James R. Wheeler, Anze Zupanic & Stefan Scholz. (2019) Building and Applying Quantitative Adverse Outcome Pathway Models for Chemical Hazard and Risk Assessment. Environmental Toxicology and Chemistry 38:9, pages 1850-1865.
Crossref
Crossref
Philippe B. Pierrillas, Emilie Henin, Kathryn Ball, Julien Ogier, Magali Amiel, Laurence Kraus-Berthier, Marylore Chenel, François Bouzom & Michel Tod. (2019) Prediction of Human Nonlinear Pharmacokinetics of a New Bcl-2 Inhibitor Using PBPK Modeling and Interspecies Extrapolation Strategy. Drug Metabolism and Disposition 47:6, pages 648-656.
Crossref
Crossref
María Elena Bravo-Gómez, Laura Nayeli Camacho-García, Luz Alejandra Castillo-Alanís, Miguel Ángel Mendoza-Meléndez & Alejandra Quijano-Mateos. (2019) Revisiting a physiologically based pharmacokinetic model for cocaine with a forensic scope. Toxicology Research 8:3, pages 432-446.
Crossref
Crossref
Dustin F. Kapraun, John F. Wambaugh, R. Woodrow Setzer & Richard S. Judson. (2019) Empirical models for anatomical and physiological changes in a human mother and fetus during pregnancy and gestation. PLOS ONE 14:5, pages e0215906.
Crossref
Crossref
Koen G. A. M. Hussaarts, G. D. Marijn Veerman, Frank G. A. Jansman, Teun van Gelder, Ron H. J. Mathijssen & Roelof W. F. van Leeuwen. (2019) Clinically relevant drug interactions with multikinase inhibitors: a review. Therapeutic Advances in Medical Oncology 11, pages 175883591881834.
Crossref
Crossref
Eva Germovsek, Charlotte I. S. Barker, Mike Sharland & Joseph F. Standing. (2018) Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance. Clinical Pharmacokinetics 58:1, pages 39-52.
Crossref
Crossref
Geoffrey A. Walford & S. Aubrey Stoch. 2019. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease
467
486
.
Philippe B. Pierrillas, Emilie Henin, Julien Ogier, Laurence Kraus-Berthier, Marylore Chenel, François Bouzom & Michel Tod. (2018) Tumor Growth Inhibition Modelling Based on Receptor Occupancy and Biomarker Activity of a New Bcl-2 Inhibitor in Mice. Journal of Pharmacology and Experimental Therapeutics 367:3, pages 414-424.
Crossref
Crossref
Jennifer Le & John S. Bradley. (2018) Optimizing Antibiotic Drug Therapy in Pediatrics: Current State and Future Needs. The Journal of Clinical Pharmacology 58, pages S108-S122.
Crossref
Crossref
Elisa A. M. Calvier, Elke H. J. Krekels, Huixin Yu, Pyry A. J. Välitalo, Trevor N. Johnson, Amin Rostami‐Hodjegan, Dick Tibboel, Piet H. van der Graaf, Meindert Danhof & Catherijne A. J. Knibbe. (2018) Drugs Being Eliminated via the Same Pathway Will Not Always Require Similar Pediatric Dose Adjustments. CPT: Pharmacometrics & Systems Pharmacology 7:3, pages 175-185.
Crossref
Crossref
Maria D. Donovan, Khaled Abduljalil, John F. Cryan, Geraldine B. Boylan & Brendan T. Griffin. (2018) Application of a physiologically-based pharmacokinetic model for the prediction of bumetanide plasma and brain concentrations in the neonate. Biopharmaceutics & Drug Disposition 39:3, pages 125-134.
Crossref
Crossref
Karol Jaroch, Alina Jaroch & Barbara Bojko. (2018) Cell cultures in drug discovery and development: The need of reliable in vitro-in vivo extrapolation for pharmacodynamics and pharmacokinetics assessment. Journal of Pharmaceutical and Biomedical Analysis 147, pages 297-312.
Crossref
Crossref
Alan Talevi & Carolina Leticia Bellera. 2018. ADME Processes in Pharmaceutical Sciences. ADME Processes in Pharmaceutical Sciences
33
53
.
Sami Haddad. 2018. Chemical Mixtures and Combined Chemical and Nonchemical Stressors. Chemical Mixtures and Combined Chemical and Nonchemical Stressors
307
333
.
Yoo-Seong Jeong, Chang-Soon Yim, Heon-Min Ryu, Chi-Kyoung Noh, Yoo-Kyung Song & Suk-Jae Chung. (2017) Estimation of the minimum permeability coefficient in rats for perfusion-limited tissue distribution in whole-body physiologically-based pharmacokinetics. European Journal of Pharmaceutics and Biopharmaceutics 115, pages 1-17.
Crossref
Crossref
T. Hartung. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
150
155
.
L. Detalle, K. Vanheusden, M.L. Sargentini-Maier & T. Stöhr. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
495
529
.
Gian P. Camenisch. (2016) Drug Disposition Classification Systems in Discovery and Development: A Comparative Review of the BDDCS, ECCS and ECCCS Concepts. Pharmaceutical Research 33:11, pages 2583-2593.
Crossref
Crossref
Gaetano Lamberti, Sara Cascone, Francesco Marra, Giuseppe Titomanlio, Matteo d’Amore & Anna Angela Barba. (2016) Gastrointestinal behavior and ADME phenomena: II. In silico simulation. Journal of Drug Delivery Science and Technology 35, pages 165-171.
Crossref
Crossref
Marie-Emilie Willemin & Annie Lumen. (2016) Development of a PBPK model of thiocyanate in rats with an extrapolation to humans: A computational study to quantify the mechanism of action of thiocyanate kinetics in thyroid. Toxicology and Applied Pharmacology 307, pages 19-34.
Crossref
Crossref
Boris V. Krivoshiev, Freddy Dardenne, Adrian Covaci, Ronny Blust & Steven J. Husson. (2016) Assessing in-vitro estrogenic effects of currently-used flame retardants. Toxicology in Vitro 33, pages 153-162.
Crossref
Crossref
Jin Zhang, Tycho Heimbach, Nico Scheer, Avantika Barve, Wenkui Li, Wen Lin & Handan He. (2016) Clinical Exposure Boost Predictions by Integrating Cytochrome P450 3A4–Humanized Mouse Studies With PBPK Modeling. Journal of Pharmaceutical Sciences 105:4, pages 1398-1404.
Crossref
Crossref
Pankaj K. Sethi, Catherine A. White, Brian S. Cummings, Ronald N. Hines, Srinivasa Muralidhara & James V. Bruckner. (2015) Ontogeny of plasma proteins, albumin and binding of diazepam, cyclosporine, and deltamethrin. Pediatric Research 79:3, pages 409-415.
Crossref
Crossref
A. A. Sprouse & R. B. van Breemen. (2015) Pharmacokinetic Interactions between Drugs and Botanical Dietary Supplements. Drug Metabolism and Disposition 44:2, pages 162-171.
Crossref
Crossref
V.R. Knight-Schrijver, V. Chelliah, L. Cucurull-Sanchez & N. Le Novère. (2016) The promises of quantitative systems pharmacology modelling for drug development. Computational and Structural Biotechnology Journal 14, pages 363-370.
Crossref
Crossref
Max Kuhn, Phillip Yates & Craig Hyde. 2016. Nonclinical Statistics for Pharmaceutical and Biotechnology Industries. Nonclinical Statistics for Pharmaceutical and Biotechnology Industries
53
81
.
Saeed Alqahtani & Amal Kaddoumi. (2015) Development of a physiologically based pharmacokinetic/pharmacodynamic model to identify mechanisms contributing to entacapone low bioavailability. Biopharmaceutics & Drug Disposition 36:9, pages 587-602.
Crossref
Crossref
Felix Stader, Gudrun Wuerthwein, Andreas H. Groll, Joerg-Janne Vehreschild, Oliver A. Cornely & Georg Hempel. (2014) Physiology-Based Pharmacokinetics of Caspofungin for Adults and Paediatrics. Pharmaceutical Research 32:6, pages 2029-2037.
Crossref
Crossref
Elizabeth C.M. de Lange. 2015. Blood‐Brain Barrier in Drug Discovery. Blood‐Brain Barrier in Drug Discovery
296
323
.
Sangeetha Aula, Samyuktha Lakkireddy, Kaiser Jamil, Atya Kapley, A. V. N. Swamy & Harivardhan Reddy Lakkireddy. (2015) Biophysical, biopharmaceutical and toxicological significance of biomedical nanoparticles. RSC Advances 5:59, pages 47830-47859.
Crossref
Crossref
Martina Heitzig, Andreas A. Linninger, Gürkan Sin & Rafiqul Gani. (2014) A computer-aided framework for development, identification and management of physiologically-based pharmacokinetic models. Computers & Chemical Engineering 71, pages 677-698.
Crossref
Crossref
Feras Khalil & Stephanie Läer. (2014) Physiologically Based Pharmacokinetic Models in the Prediction of Oral Drug Exposure Over the Entire Pediatric Age Range—Sotalol as a Model Drug. The AAPS Journal 16:2, pages 226-239.
Crossref
Crossref
Carole E. Shardlow, Grant T. Generaux, Aarti H. Patel, Guoying Tai, Thuy Tran & Jackie C. Bloomer. (2013) Impact of Physiologically Based Pharmacokinetic Modeling and Simulation in Drug Development. Drug Metabolism and Disposition 41:12, pages 1994-2003.
Crossref
Crossref
Kathryn Ball, François Bouzom, Jean-Michel Scherrmann, Bernard Walther & Xavier Declèves. (2013) Physiologically Based Pharmacokinetic Modelling of Drug Penetration Across the Blood–Brain Barrier—Towards a Mechanistic IVIVE-Based Approach. The AAPS Journal 15:4, pages 913-932.
Crossref
Crossref
Andrej Mošat’, Eric Lueshen, Martina Heitzig, Cierra Hall, Andreas A. Linninger, Gürkan Sin & Rafiqul Gani. (2013) First principles pharmacokinetic modeling: A quantitative study on Cyclosporin. Computers & Chemical Engineering 54, pages 97-110.
Crossref
Crossref
F. YANG, N. SUN, Y. X. SUN, Q. SHAN, H. Y. ZHAO, D. P. ZENG & Z. L. ZENG. (2013) A physiologically based pharmacokinetics model for florfenicol in crucian carp and oral-to-intramuscular extrapolation. Journal of Veterinary Pharmacology and Therapeutics 36:2, pages 192-200.
Crossref
Crossref
Jens Niklas, Juan G Diaz Ochoa, Joachim Bucher & Klaus Mauch. (2012) Quantitative Evaluation and Prediction of Drug Effects and Toxicological Risk Using Mechanistic Multiscale Models. Molecular Informatics 32:1, pages 14-23.
Crossref
Crossref
Kathryn Ball, François Bouzom, Jean-Michel Scherrmann, Bernard Walther & Xavier Declèves. (2012) Development of a Physiologically Based Pharmacokinetic Model for the Rat Central Nervous System and Determination of an In Vitro–In Vivo Scaling Methodology for the Blood–Brain Barrier Permeability of Two Transporter Substrates, Morphine and Oxycodone. Journal of Pharmaceutical Sciences 101:11, pages 4277-4292.
Crossref
Crossref
Kenneth T. Luu, Simon Bergqvist, Enhong Chen, Dana Hu-Lowe & Eugenia Kraynov. (2012) A Model-Based Approach to Predicting the Human Pharmacokinetics of a Monoclonal Antibody Exhibiting Target-Mediated Drug Disposition. Journal of Pharmacology and Experimental Therapeutics 341:3, pages 702-708.
Crossref
Crossref
Cierra Hall, Eric Lueshen, Andrej Mošat'Andreas A. Linninger. (2012) Interspecies Scaling in Pharmacokinetics: A Novel Whole-Body Physiologically Based Modeling Framework to Discover Drug Biodistribution Mechanisms in vivo. Journal of Pharmaceutical Sciences 101:3, pages 1221-1241.
Crossref
Crossref
François Bouzom, Kathryn Ball, Nathalie Perdaems & Bernard Walther. (2012) Physiologically based pharmacokinetic (PBPK) modelling tools: how to fit with our needs?. Biopharmaceutics & Drug Disposition 33:2, pages 55-71.
Crossref
Crossref
Jared L. Crandon & David P. Nicolau. 2012. Antibiotic Discovery and Development. Antibiotic Discovery and Development
1035
1054
.
Lars Kuepfer, Jörg Lippert & Thomas Eissing. 2012. Advances in Systems Biology. Advances in Systems Biology
543
561
.
Matthew D. Thompson & Daniel A. Beard. (2012) Physiologically Based Pharmacokinetic Tissue Compartment Model Selection in Drug Development and Risk Assessment. Journal of Pharmaceutical Sciences 101:1, pages 424-435.
Crossref
Crossref
Joost Westerhout, Meindert Danhof & Elizabeth C.M. De Lange. (2011) Preclinical Prediction of Human Brain Target Site Concentrations: Considerations in Extrapolating to the Clinical Setting. Journal of Pharmaceutical Sciences 100:9, pages 3577-3593.
Crossref
Crossref
Brioni R. Moore, Madhu Page-Sharp, Jillian R. Stoney, Kenneth F. Ilett, Jeffrey D. Jago & Kevin T. Batty. (2011) Pharmacokinetics, Pharmacodynamics, and Allometric Scaling of Chloroquine in a Murine Malaria Model. Antimicrobial Agents and Chemotherapy 55:8, pages 3899-3907.
Crossref
Crossref
Joao Paulo Mattos Almeida, Allen L Chen, Aaron Foster & Rebekah Drezek. (2011)
In vivo
biodistribution of nanoparticles
. Nanomedicine 6:5, pages 815-835.
Crossref
Crossref
Jim E. RiviereTeresa Leavens. 2011. Comparative Pharmacokinetics. Comparative Pharmacokinetics
225
240
.
Malcolm RowlandCarl Peck & Geoffrey Tucker. (2011) Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science. Annual Review of Pharmacology and Toxicology 51:1, pages 45-73.
Crossref
Crossref
Xavier Boulenc & Olivier Barberan. (2011) Metabolic-based drug-drug interactions prediction, recent approaches for risk assessment along drug development. Drug Metabolism and Drug Interactions 26:4.
Crossref
Crossref
Feras Khalil & Stephanie Läer. (2011) Physiologically Based Pharmacokinetic Modeling: Methodology, Applications, and Limitations with a Focus on Its Role in Pediatric Drug Development. Journal of Biomedicine and Biotechnology 2011, pages 1-13.
Crossref
Crossref
Johannes N. van den Anker, Matthias Schwab & Gregory L. Kearns. 2011. Pediatric Clinical Pharmacology. Pediatric Clinical Pharmacology
51
75
.
Xavier Boulenc, Wolfgang Schmider & Olivier Barberan. 2011. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
133
160
.